flutamide has been researched along with Alveolar Bone Atrophy in 1 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steffens, JP | 1 |
| Coimbra, LS | 1 |
| Rossa, C | 1 |
| Kantarci, A | 1 |
| Van Dyke, TE | 1 |
| Spolidorio, LC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical, Microbiologic and Immunologic Profile of the Periodontal Condition in Hypogonadic Men[NCT03176537] | Phase 4 | 0 participants (Actual) | Interventional | 2017-05-01 | Withdrawn (stopped due to No eligible participants for the RCT were found) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for flutamide and Alveolar Bone Atrophy
| Article | Year |
|---|---|
Androgen receptors and experimental bone loss - an in vivo and in vitro study.
Topics: Alveolar Bone Loss; Androgen Receptor Antagonists; Animals; Disease Models, Animal; Flutamide; In Vi | 2015 |